AQR Arbitrage’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-252,300
Closed -$23.4M 1582
2021
Q4
$23.4M Buy
+252,300
New +$16.6M 0.6% 36

AQR Arbitrage's ARNA Position: Q1 2022 in Review

AQR Arbitrage sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 252,300 shares — an estimated $23.4M sold.

AQR Arbitrage first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $23.4M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • AQR Arbitrage reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • AQR Arbitrage sold 252,300 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $23.4M.
  • AQR Arbitrage first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • AQR Arbitrage's Arena Pharmaceuticals Inc position peaked at $23.4M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on AQR Arbitrage's 13F filing for Q1 2022, filed 16 May 2022.